v3.26.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 3,868 $ 3,955 $ 11,715 $ 22,737
General and administrative 7,406 7,905 20,120 59,101
Total operating expenses 11,274 11,860 31,835 81,838
Operating loss (11,274) (11,860) (31,835) (81,838)
Interest income 520 1,167 2,056 3,646
Other income (loss), net 28 (114) 119 (242)
Net loss $ (10,726) $ (10,807) $ (29,660) $ (78,434)
Net loss per share, basic and diluted (in dollars per share) $ (0.22) $ (0.22) $ (0.61) $ (1.62)